UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

BMJ Oncology, 2023-04, Vol.2 (1), p.e000039

2023

Volltextzugriff (PDF)

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.235-239

2006

Volltextzugriff (PDF)

Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study

PloS one, 2021-06, Vol.16 (6 June 2021)

2021

Volltextzugriff (PDF)

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.024

European urology, 2016

2016

Volltextzugriff (PDF)

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11

European urology, 2013-11, Vol.64 (5), p.711-712

2013

Volltextzugriff (PDF)

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11: Should Men Older Than Age 70 Be Recommended Against Screening?

European urology, 2013-11, Vol.64 (5), p.711-712

2013

Volltextzugriff (PDF)

The quality of radical prostatectomies must be ensured

Läkartidningen, 2017-07, Vol.114

2017

Volltextzugriff (PDF)

The impact of design and performance in PSA screening: differences between ERSPC centers

European urology, 2019-04, Vol.76 (3), p.276-279

2019

Volltextzugriff (PDF)

Prostate cancer - diagnostics and screening: Prostatacancer – utredning, klinisk diagnostik och screening

Läkartidningen, 2024, Vol.121

2024

Volltextzugriff (PDF)

MP46-02 PROSTATE CANCER SCREENING NOMOGRAM PREDICTING 15-YEAR RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER, DEVELOPED USING COMPETING RISK ANALYSIS

The Journal of urology, 2018-04, Vol.199 (4S)

2018

Volltextzugriff (PDF)

MP46-01 DEVELOPMENT OF PROSTATE CANCER SCREENING NOMOGRAMS FOR PREDICTING 15-YEAR RISK OF PROSTATE CANCER DIAGNOSIS AND PROSTATE CANCER MORTALITY, WITH OTHER-CAUSE MORTALITY AS COMPETING EVENT

The Journal of urology, 2018-04, Vol.199 (4S)

2018

Volltextzugriff (PDF)

PD35-04 COULD DIFFERENCES IN TREATMENT BETWEEN TRIAL ARMS EXPLAIN THE REDUCTION IN PROSTATE CANCER MORTALITY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER?

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.87-87

2019

Volltextzugriff (PDF)

Kvaliteten på radikal prostatektomi måste säkerställas: fortlöpande förbättringsarbete behövs på varje klinik - med patientenkäter kan enskilda kirurgers resultat följas upp

Läkartidningen, 2017, Vol.114 (27-29)

2017

Volltextzugriff (PDF)

Correction: Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial

Hernia : the journal of hernias and abdominal wall surgery, 2022-04, Vol.26 (2), p.683-683

2022

Volltextzugriff (PDF)

Development of prostate-specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.110-110

2018

Volltextzugriff (PDF)

MP18-16 INDIVIDUAL DATA META-ANALYSIS OF DISCRIMINATION OF THE STATISTICAL MODEL BASED ON THE FOUR KALLIKREIN PANEL ASSOCIATED WITH THE INCLUSION OF PROSTATE VOLUME

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

MP60-06 90-DAY READMISSION AFTER RADICAL PROSTATECTOMY - A PROSPECTIVE COMPARISON BETWEEN ROBOT-ASSISTED AND OPEN SURGERY

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

Reply from Authors re: Urs E. Studer, Peter C. Albertsen. It's Time to Change the Treatment Paradigm for Prostate Cancer! Eur Urol 2013;63:97–9

European urology, 2013-01, Vol.63 (1), p.99-100

2013

Volltextzugriff (PDF)

PD13-04 PROSTATE CANCER SPECIFIC MORTALITY IN THE ERSPC TRIAL: WHAT IS THE ROLE OF SCREENING RESULT AND ADHERENCE

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

Four‐hundredfold overestimation of biopsy mortality

BJU international, 2013-03, Vol.111 (3), p.E16-E17

2013

Volltextzugriff (PDF)

Prostate cancer screening in Europe – Authors' reply

The Lancet (British edition), 2015-04, Vol.385 (9977), p.1507-1508

2015

Volltextzugriff (PDF)

PD15-07 ERECTILE-FUNCTION AND ONCOLOGIC OUTCOMES AFTER OPEN RETROPUBIC AND ROBOT-ASSISTED RADICAL PROSTATECTOMY: RESULTS FROM A LARGE, PROSPECTIVE SWEDISH TRIAL

The Journal of urology, 2017-04, Vol.197 (4S)

2017

Volltextzugriff (PDF)

Screening for Prostate Cancer Starting at Age 50-54. A Population-based Cohort Study

European urology, 2016-04, Vol.71 (1), p.46-52

2016

Volltextzugriff (PDF)

90-Day readmission after radical prostatectomy-a prospective comparison between robot-assisted and open surgery

Scandinavian journal of urology, 2019, Vol.53 (1), p.26-33

2019

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Aktive Filter

ThemaProstate-Specific Antigen - Blood

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Englisch
(101)
Schwedisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.024

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11: Should Men Older Than Age 70 Be Recommended Against Screening?

The quality of radical prostatectomies must be ensured

The impact of design and performance in PSA screening: differences between ERSPC centers

Prostate cancer - diagnostics and screening: Prostatacancer – utredning, klinisk diagnostik och screening

MP46-02 PROSTATE CANCER SCREENING NOMOGRAM PREDICTING 15-YEAR RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER, DEVELOPED USING COMPETING RISK ANALYSIS

MP46-01 DEVELOPMENT OF PROSTATE CANCER SCREENING NOMOGRAMS FOR PREDICTING 15-YEAR RISK OF PROSTATE CANCER DIAGNOSIS AND PROSTATE CANCER MORTALITY, WITH OTHER-CAUSE MORTALITY AS COMPETING EVENT

PD35-04 COULD DIFFERENCES IN TREATMENT BETWEEN TRIAL ARMS EXPLAIN THE REDUCTION IN PROSTATE CANCER MORTALITY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER?

Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making

Kvaliteten på radikal prostatektomi måste säkerställas: fortlöpande förbättringsarbete behövs på varje klinik - med patientenkäter kan enskilda kirurgers resultat följas upp

Correction: Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial

Development of prostate-specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM)

MP18-16 INDIVIDUAL DATA META-ANALYSIS OF DISCRIMINATION OF THE STATISTICAL MODEL BASED ON THE FOUR KALLIKREIN PANEL ASSOCIATED WITH THE INCLUSION OF PROSTATE VOLUME

MP60-06 90-DAY READMISSION AFTER RADICAL PROSTATECTOMY - A PROSPECTIVE COMPARISON BETWEEN ROBOT-ASSISTED AND OPEN SURGERY

Reply from Authors re: Urs E. Studer, Peter C. Albertsen. It's Time to Change the Treatment Paradigm for Prostate Cancer! Eur Urol 2013;63:97–9

PD13-04 PROSTATE CANCER SPECIFIC MORTALITY IN THE ERSPC TRIAL: WHAT IS THE ROLE OF SCREENING RESULT AND ADHERENCE

Four‐hundredfold overestimation of biopsy mortality

Prostate cancer screening in Europe – Authors' reply

PD15-07 ERECTILE-FUNCTION AND ONCOLOGIC OUTCOMES AFTER OPEN RETROPUBIC AND ROBOT-ASSISTED RADICAL PROSTATECTOMY: RESULTS FROM A LARGE, PROSPECTIVE SWEDISH TRIAL

Screening for Prostate Cancer Starting at Age 50-54. A Population-based Cohort Study

90-Day readmission after radical prostatectomy-a prospective comparison between robot-assisted and open surgery

Aktive Filter

Suchergebnisse filtern